Back

Implantation of human iPS cell-derived engineered cardiac tissues including cardiomyocytes and multiple vascular lineages ameliorates cardiac dysfunction after myocardial infarction in a rat model

27 August 2016 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 4 - Cell and gene therapy Stem cells and cell therapy ESC Premium Access ESC Congress 2016

About the speaker

Photo
Doctor Hidetoshi Masumoto

RIKEN Center for Biosystems Dynamics Research (BDR), Kobe (Japan)

15 More presentations in this session

Presentation thumbnail
Prolyl hydroxylase inhibition to enhance SDF-1 and CXCR4 expression for increased CXCR4+ cell homing and myocardial repair
Doctor S. Ghadge (Vienna, AT)
Abstract Slides
Presentation thumbnail
Cardiac regeneration in nonischemic cardiomyopathy
Doctor Y. Liu (New Taipei, TW)
Abstract
Presentation thumbnail
The effect of DPP-4 inhibitor on angiogenic regeneration by bone marrow mesenchymal stem cell in hind-limb ischemia injury model
Associate Professor J. Oh (Seoul, KR)
Abstract
Presentation thumbnail
FOXO1A modifies arterial and venous endothelial development from human pluripotent stem cells; they establish 3D vascular structures in vitro and quantifiable vascular networks in vivo
Doctor E. Gara (Budapest, HU)
Abstract
Presentation thumbnail
Systemic insulin resistance and adipose tissue inflammation predict decreased therapeutic mesenchymal stem cells for autologous transplantation in patients with cardiovascular disease
Doctor O. Inoue (Kanazawa, JP)
Abstract Slides

Access the full session

Session thumbnail
Poster session 4 - Cell and gene therapy

The Event

Event poster

ESC Congress 2016

27 August - 31 August 2016

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources